Profile
Helen E.
Heslop is the founder of AlloVir, Inc. (2013) and Tikva Allocell Pte Ltd. (2023).
Dr. Heslop is currently the Director at Center For Cell & Gene Therapy and the Deputy Director at Dan L.
Duncan Comprehensive Cancer Center.
Helen Heslop active positions
| Companies | Position | Start |
|---|---|---|
Dan L. Duncan Comprehensive Cancer Center | Corporate Officer/Principal | - |
Center For Cell & Gene Therapy | Director/Board Member | - |
Former positions of Helen Heslop
| Companies | Position | End |
|---|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization dedicated to funding research, education and support services for all blood cancers | Director/Board Member | - |
| ALLOVIRPAR | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization dedicated to funding research, education and support services for all blood cancers | Commercial Services |
AlloVir, Inc.
AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Center For Cell & Gene Therapy | |
Dan L. Duncan Comprehensive Cancer Center |
- Stock Market
- Insiders
- Helen Heslop
















